1.
Rigodanza L. CO33 | Variant-specific prognostic impact of SRSF2 p95 mutations in ASXL1-mutated myelodysplastic syndromes: <a href="https://haematologica.org/search/search?query=L.+Rigodanza">Luca Rigodanza</a><sup>1|2</sup>, <a href="https://haematologica.org/search/search?query=G.+Mattiuz">G. Mattiuz</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=S.+De+Pourcq">S. De Pourcq</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=G.+andreossi">G. andreossi</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=V.+Santini">V. Santini</a><sup>2</sup> | <i><sup>1</sup>U. O. C. Ematologia, Ospedale San Bortolo; <sup>2</sup>MDS Unit, Università di Firenze, AOUC, Italy.</i&gt;. Haematologica;111(s1):; https://doi.org/10.3324/haematol.2026.s1.42.